Pilulka Lékárny a.s. Income Statement

Financials in millions CZK. Fiscal year is January - December.

Millions CZK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,304	2,132	2,447	2,380
Revenue Growth (YoY)	-38.82%	-12.89%	2.81%	-
Cost of Revenue	1,121	1,835	2,047	2,367
Gross Profit	183.46	297.34	400.7	13.52
Selling, General & Admin	229.16	364.46	400.43	-
Other Operating Expenses	-8.69	7.51	-2.67	15.4
Operating Expenses	293.38	445.91	448.47	27.51
Operating Income	-109.92	-148.57	-47.77	-13.99
Interest Expense	-12.33	-10.48	-4.76	-0.78
Interest & Investment Income	0.01	0.05	0.21	0.71
Other Non Operating Income (Expenses)	-12.68	-16.88	-11.78	-10.63
EBT Excluding Unusual Items	-134.93	-175.89	-64.11	-24.68
Gain (Loss) on Sale of Assets	8.56	0.02	0.1	-
Pretax Income	-126.38	-175.87	-64.01	-24.68
Income Tax Expense	-	0	1.75	0.99
Earnings From Continuing Operations	-126.38	-175.88	-65.76	-25.67
Minority Interest in Earnings	0.64	0.93	0.82	0.18
Net Income	-125.74	-174.94	-64.94	-25.5
Net Income to Common	-125.74	-174.94	-64.94	-25.5
Shares Outstanding (Basic)	-	3	3	-
Shares Outstanding (Diluted)	-	3	3	-
Shares Change (YoY)	-	7.36%	-	-
EPS (Basic)	-	-64.63	-25.76	-
EPS (Diluted)	-	-64.63	-25.76	-
Free Cash Flow	-65.05	-69.92	-114.92	-57.46
Free Cash Flow Per Share	-	-25.83	-45.59	-
Gross Margin	14.07%	13.95%	16.37%	0.57%
Operating Margin	-8.43%	-6.97%	-1.95%	-0.59%
Profit Margin	-9.64%	-8.21%	-2.65%	-1.07%
Free Cash Flow Margin	-4.99%	-3.28%	-4.70%	-2.41%
EBITDA	-45.63	-125.75	-29.92	8.33
EBITDA Margin	-3.50%	-5.90%	-1.22%	0.35%
D&A For EBITDA	64.29	22.83	17.85	22.31
EBIT	-109.92	-148.57	-47.77	-13.99
EBIT Margin	-8.43%	-6.97%	-1.95%	-0.59%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.